Significantly rebounded. Kidswell Bio <4584> announced the conclusion of a basic agreement on business partnership related to the development of biosimilar pharmaceuticals. Both companies will share their experience and know-how in the development of biopharmaceuticals they hold, as well as sharing the costs related to development investment. The revenue obtained by transferring or licensing cell strains and manufacturing processes developed through the cooperation of both companies to pharmaceutical companies will be profit shared by both companies, aiming to establish a new source of revenue.